BERLIN, May 05, 2025--(BUSINESS WIRE)--Regulatory News: TME Pharma N.V. (Euronext Growth Paris: ALTME), a clinical-stage biotechnology company focused on developing novel therapies for treatment ...

President Donald Trump took on Big Pharma Monday with an executive order that will reduce the prices for prescriptions. The president said the U.S. “will no longer tolerate profiteering and ...

A logo is a big part of any major company's brand identity. It takes a lot of work to create a simple little image that the average consumer can immediately associate with certain features and ...

HERZLIYA, Israel and CALGARY, AB, May 6, 2025 /CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in the ...

Indian pharma stocks fell 1.6% on Monday (May 12, 2025), bucking broader market gains, after U.S. President Donald Trump said he would cut drug prices by 30%–80% to match other wealthy nations.

Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter ...

President Trump's executive order on drug pricing caused a surprising rally in pharmaceutical stocks, despite initial fears of negative impacts on profit margins. The order lacks enforcement ...

Innocan's first fully-granted patent in Mexico Covers Innocan's proprietary cannabis-based pain relief topical Indication of Innocan's growing intellectual property portfolio This patent covers a ...

Big Pharma isn’t sure how to handle Donald Trump’s Republican Party. Trump is pledging to impose tariffs on drug imports, while Health Secretary Robert F. Kennedy Jr. has vilified the drug ...

The Trump administration’s threat of pharmaceutical tariffs could risk significant political backlash, as the drug industry and outside experts are raising red flags over worsening shortages and ...

Indian pharmaceutical firms can explore opportunities in regions such as Europe, Africa, and Latin America, focusing on high-margin products while optimizing their supply chains. Trump has ...

Ahmedabad: Gujarat has further cemented its position as India's pharmaceutical powerhouse with the state's Food and Drug Control Administration (FDCA) approving 183 new allopathic drug ...